Home » Stocks » MTP

Midatech Pharma PLC (MTP)

Stock Price: $1.92 USD -0.02 (-1.03%)
Updated December 3, 4:00 PM EST - Market closed
After-hours: $1.90 -0.02 (-1.04%) Dec 3, 7:16 PM

Stock Price Chart

Key Info

Market Cap 24.21M
Revenue (ttm) 886,842
Net Income (ttm) -13.27M
Shares Out 12.24M
EPS (ttm) -0.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $1.92
Previous Close $1.94
Change ($) -0.02
Change (%) -1.03%
Day's Open 1.96
Day's Range 1.82 - 1.96
Day's Volume 342,783
52-Week Range 1.22 - 5.20

More Stats

Market Cap 24.21M
Enterprise Value 17.83M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 12.24M
Float n/a
EPS (basic) n/a
EPS (diluted) -0.85
FCF / Share -4.69
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 136,604
Short Ratio 0.20
Short % of Float n/a
Beta 2.02
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 27.30
PB Ratio 4.01
Revenue 886,842
Operating Income -14.91M
Net Income -13.27M
Free Cash Flow -11.47M
Net Cash 6.38M
Net Cash / Share 0.50
Gross Margin 100.00%
Operating Margin -1,681.45%
Profit Margin -1,496.30%
FCF Margin -1,293.62%
ROA -32.28%
ROE -151.13%
ROIC -188.20%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$1,575*
Low
1,575
Current: $1.92
High
1,575
Target: 1,575
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions GBP.

Financial Overview

Year2019201820172016201520142013
Revenue0.671.940.991.321.380.160.15
Revenue Growth-65.22%95.96%-25.25%-3.78%775.8%6.8%-
Gross Profit0.671.940.991.321.310.160.15
Operating Income-11.33-11.82-13.28-9.65-12.92-9.69-4.50
Net Income-10.09-15.03-16.06-20.16-10.10-8.82-4.08
Shares Outstanding12.2412.229.746.696.692.861.03
Earnings Per Share-2.75-24.60-31.30-14.00-9.00-24.50-17.75
Operating Cash Flow-8.41-14.81-14.41-14.74-13.07-6.25-5.02
Capital Expenditures-0.31-0.22-0.71-1.35-0.92-1.03-0.05
Free Cash Flow-8.72-15.03-15.12-16.08-13.99-7.28-5.07
Cash & Equivalents10.932.3413.2017.6116.1830.332.39
Total Debt6.081.256.552.161.951.983.37
Net Cash / Debt4.851.096.6615.4514.2328.35-0.98
Assets30.9020.4449.2256.6964.0446.665.17
Liabilities11.343.5214.5510.9717.154.674.41
Book Value19.5616.9234.6845.7246.8941.990.76
Numbers in millions GBP, except per-share numbers.

Company Profile

Company Details

Full Name Midatech Pharma PLC
Employees 65

Stock Information

Ticker Symbol MTP
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: MTP

Description

Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTD201, a long acting dose of Octreotide for the treatment of acromegaly and neuroendocrine tumors; and MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma. It also offers drug delivery platforms, such as Q-Sphera, a microencapsulation and polymer-depot sustained release drug delivery platform; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. Midatech Pharma plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.